Risk factors for in vivo emergence of ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae and the associated resistance mechanisms: a case-control study | Synapse
May 6, 2026Open Access
Risk factors for in vivo emergence of ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae and the associated resistance mechanisms: a case-control study
Key Points
This research aims to identify risk factors associated with the emergence of ceftazidime-avibactam resistance in Klebsiella pneumoniae.
Case-control design comparing patients with and without ceftazidime-avibactam resistance.
Analysis of infection and resistance mechanisms in KPC-producing Klebsiella pneumoniae.
Data collection on clinical and microbiological profiles.
Identified specific risk factors contributing to resistance emergence.
Demonstrated association between certain clinical variables and increased resistance rates.
Provided insights into the mechanisms underpinning ceftazidime-avibactam resistance.